Ho Peter Tai-Ching

Chief Development Officer at Epizyme, Inc.

Sold, on record
$1.4M
Dollars the filings state
Form 4 sales
7
Latest Oct 24, 2017
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Epizyme, Inc.Plan not stated
    Dec 8, 2016 2016

    Sold 200 shares at $10.89 ($2k)

    Ho Peter Tai-Ching, Chief Development Officer

    Sold 3.5% of holdings ($62k position)5,520 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Epizyme, Inc.Unusual
    May 25, 2017 +168 days

    Sold 15,000 shares at $16.11 ($242k)

    Ho Peter Tai-Ching, Chief Development Officer

    Sold 67.5% of holdings ($358k position)7,228 shares leftFiling

  3. 3 Form 4 sale Epizyme, Inc.Unusual
    Jun 26, 2017 +32 days

    Sold 15,000 shares at $14.87 ($223k)

    Ho Peter Tai-Ching, Chief Development Officer

    Sold 67.5% of holdings ($331k position)7,228 shares leftFiling

  4. 4 Form 4 sale Epizyme, Inc.Unusual
    Jul 24, 2017 +28 days

    Sold 15,000 shares at $13.44 ($202k)

    Ho Peter Tai-Ching, Chief Development Officer

    Sold 67.5% of holdings ($299k position)7,228 shares left1x usual sizeFiling

  5. 5 Form 4 sale Epizyme, Inc.Unusual
    Aug 24, 2017 +31 days

    Sold 15,000 shares at $15.68 ($235k)

    Ho Peter Tai-Ching, Chief Development Officer

    Sold 67.5% of holdings ($349k position)7,228 shares left1x usual sizeFiling

  6. 6 Form 4 sale Epizyme, Inc.Unusual
    Sep 25, 2017 +32 days

    Sold 15,000 shares at $16.81 ($252k)

    Ho Peter Tai-Ching, Chief Development Officer

    Sold 64.9% of holdings ($389k position)8,123 shares left1x usual sizeFiling

  7. 7 Form 4 sale Epizyme, Inc.Unusual
    Oct 24, 2017 +29 days

    Sold 15,000 shares at $16.44 ($247k)

    Ho Peter Tai-Ching, Chief Development Officer

    Sold 64.9% of holdings ($380k position)8,123 shares left1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (7)

Form 144 notices and Form 4 sales by Ho Peter Tai-Ching
Source
Oct 24, 2017Oct 25, 2017Epizyme, Inc.Chief Development OfficerForm 4 sale15,000$247k64.9%UnusualSEC
Sep 25, 2017Sep 26, 2017Epizyme, Inc.Chief Development OfficerForm 4 sale15,000$252k64.9%UnusualSEC
Aug 24, 2017Aug 28, 2017Epizyme, Inc.Chief Development OfficerForm 4 sale15,000$235k67.5%UnusualSEC
Jul 24, 2017Jul 26, 2017Epizyme, Inc.Chief Development OfficerForm 4 sale15,000$202k67.5%UnusualSEC
Jun 26, 2017Jun 27, 2017Epizyme, Inc.Chief Development OfficerForm 4 sale15,000$223k67.5%UnusualSEC
May 25, 2017May 26, 2017Epizyme, Inc.Chief Development OfficerForm 4 sale15,000$242k67.5%UnusualSEC
Dec 8, 2016Dec 12, 2016Epizyme, Inc.Chief Development OfficerForm 4 sale200$2k3.5%Plan not statedSEC